EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Foreword: Preventing COVID-19 Among the Immunocompromised Population

Michelle Willicombe

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiad106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Michelle Willicombe. Beteiligte Einrichtung: Department of Immunology and Inflammation, Imperial College London, London, UK. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moderna Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic represented 1 of the more significant and unique public health challenges facing the global community, particularly afflicting those with compromised immune systems. These immunocompromised individuals were readily recognized as a group at high risk of infection by SARS-CoV-2 and the associated severe outcomes of COVID-19. Although preventive strategies such as vaccination are important, initial clinical vaccine trials did not enroll immunocompromised individuals; in-depth evaluations of the safety, immunogenicity, and real-world outcomes associated with these vaccines were conducted in this population thereafter. As immunogenicity data of COVID-19 vaccination among this disparate group of individuals emerged, vaccination strategies were adapted to address outstanding challenges and further protect the entirety of this population. This 8-part journal supplement characterizes in-depth the mRNA-based COVID-19 vaccination strategies across the spectrum of immunocompromised individuals, focusing on the ongoing approaches to challenges facing this group as the pandemic continues to evolve.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2COVID-19 VaccinesPandemicsDietary SupplementsVaccination

Stichwörter der Autor:innen

COVID-19immunocompromised individualsmRNA-based vaccines

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Immunology and Inflammation, Imperial College London, London, UK.

Förderung

  • Moderna Inc

Zitieren

APA

Willicombe, M. (2023). Foreword: Preventing COVID-19 Among the Immunocompromised Population. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad106

Vancouver

Willicombe M. Foreword: Preventing COVID-19 Among the Immunocompromised Population. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad106

BibTeX
@article{Willicombe2023,
  author = {Willicombe, Michelle},
  title = {Foreword: Preventing COVID-19 Among the Immunocompromised Population},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiad106}
}
Kostenlos starten →